Analysts expect Insulet Co. (NASDAQ:PODD – Get Rating) to report earnings of $0.23 per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Insulet’s earnings, with estimates ranging from $0.15 to $0.28. The firm is scheduled to report its next earnings report after the market closes on Monday, […]
Wall Street analysts predict that Insulet Co. (NASDAQ:PODD – Get Rating) will announce sales of $286.84 million for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Insulet’s earnings. The lowest sales estimate is $284.10 million and the highest is $291.00 million. Insulet reported sales of $252.30 million during the […]
Assenagon Asset Management S.A. grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 284.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 13,052 shares of the medical instruments supplier’s stock after buying an additional 9,659 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Insulet were worth $3,473,000 as of its […]
Oppenheimer Asset Management Inc. grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,622 shares of the medical instruments supplier’s stock after buying an additional 57 shares during the quarter. Oppenheimer […]
Nomura Asset Management Co. Ltd. raised its holdings in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 6.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 73,655 shares of the medical instruments supplier’s stock after acquiring an additional 4,404 shares during the […]